These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A redox switch regulates the structure and function of anti-apoptotic BFL-1. Korshavn KJ; Wales TE; Bird GH; Engen JR; Walensky LD Nat Struct Mol Biol; 2020 Sep; 27(9):781-789. PubMed ID: 32661419 [TBL] [Abstract][Full Text] [Related]
4. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor. Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells. Feng X; Yan Z; Zhou F; Lou J; Lyu X; Ren X; Zeng Z; Liu C; Zhang S; Zhu D; Huang H; Yang J; Zhao Y Eur J Med Chem; 2022 Jun; 236():114327. PubMed ID: 35385805 [TBL] [Abstract][Full Text] [Related]
6. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent. Modi V; Lama D; Sankararamakrishnan R J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956 [TBL] [Abstract][Full Text] [Related]
7. Selective Covalent Targeting of Anti-apoptotic BFL-1 by a Sulfonium-Tethered Peptide. Liu N; Wang D; Lian C; Zhao R; Tu L; Zhang Y; Liu J; Zhu H; Yu M; Wan C; Li D; Li S; Yin F; Li Z Chembiochem; 2021 Jan; 22(2):340-344. PubMed ID: 32790056 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a Covalent Inhibitor That Overcame Resistance to Venetoclax in AML Cells Overexpressing BFL-1. Lou J; Zhou Q; Lyu X; Cen X; Liu C; Yan Z; Li Y; Tang H; Liu Q; Ding J; Lu Y; Huang H; Xie H; Zhao Y J Med Chem; 2024 Jul; 67(13):10795-10830. PubMed ID: 38913996 [TBL] [Abstract][Full Text] [Related]
9. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. Werner AB; de Vries E; Tait SW; Bontjer I; Borst J J Biol Chem; 2002 Jun; 277(25):22781-8. PubMed ID: 11929871 [TBL] [Abstract][Full Text] [Related]
10. Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer. Guerra RM; Bird GH; Harvey EP; Dharia NV; Korshavn KJ; Prew MS; Stegmaier K; Walensky LD Cell Rep; 2018 Sep; 24(13):3393-3403.e5. PubMed ID: 30257201 [TBL] [Abstract][Full Text] [Related]
11. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents. Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy. Li X; Dou J; You Q; Jiang Z Eur J Med Chem; 2021 Aug; 220():113539. PubMed ID: 34034128 [TBL] [Abstract][Full Text] [Related]
13. Identification of Small Inhibitory Molecules Targeting the Bfl-1 Anti-Apoptotic Protein That Alleviates Resistance to ABT-737. Mathieu AL; Sperandio O; Pottiez V; Balzarin S; Herlédan A; Elkaïm JO; Fogeron ML; Piveteau C; Dassonneville S; Deprez B; Villoutreix BO; Bonnefoy N; Leroux F J Biomol Screen; 2014 Aug; 19(7):1035-46. PubMed ID: 24809353 [TBL] [Abstract][Full Text] [Related]
14. Structure-Based Optimization of a Series of Covalent, Cell Active Bfl-1 Inhibitors. Lucas SCC; Blackwell JH; Börjesson U; Hargreaves D; Milbradt AG; Bostock MJ; Ahmed S; Beaumont K; Cheung T; Demanze S; Gohlke A; Guerot C; Haider A; Kantae V; Kauffman GW; Kinzel O; Kupcova L; Lainchbury MD; Lamb ML; Leon L; Palisse A; Sacchetto C; Storer RI; Su N; Thomson C; Vales J; Chen Y; Hu X J Med Chem; 2024 Sep; 67(18):16455-16479. PubMed ID: 39291659 [TBL] [Abstract][Full Text] [Related]
15. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells. Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914 [TBL] [Abstract][Full Text] [Related]
16. Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1. Jenson JM; Ryan JA; Grant RA; Letai A; Keating AE Elife; 2017 Jun; 6():. PubMed ID: 28594323 [TBL] [Abstract][Full Text] [Related]
20. Conversion of Bfl-1, an anti-apoptotic Bcl-2 family protein, to a potent pro-apoptotic protein by fusion with green fluorescent protein (GFP). Ko JK; Choi KH; Kim HJ; Choi HY; Yeo DJ; Park SO; Yang WS; Kim YN; Kim CW FEBS Lett; 2003 Sep; 551(1-3):29-36. PubMed ID: 12965200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]